Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.056 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.04 | 0.7 |